Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.94 |
| ▸ | XDH | P47989 | 4/20 | 0.94 |
| ▸ | MAOA | P21397 | 3/20 | 0.94 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.94 |
| ▸ | MAPT | P10636 | 2/20 | 0.94 |
| ▸ | HES1 | Q14469 | 2/20 | 0.94 |
| ▸ | FANCF | Q9NPI8 | 2/20 | 0.94 |
| ▸ | POLB | P06746 | 2/20 | 0.94 |
| ▸ | GAA | P10253 | 2/20 | 0.94 |
| ▸ | KDM1A | O60341 | 1/20 | 0.94 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.94 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.94 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.94 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.94 |
| ▸ | CFTR | P13569 | 1/20 | 0.94 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.94 |
| ▸ | ACHE | P22303 | 1/20 | 0.94 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.94 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.94 |
| ▸ | BACE1 | P56817 | 1/20 | 0.94 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rutin SCHEMBL17263228 | 0.99 | KDM4E (0.92) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL20339279 | 0.97 | KDM4E (0.88) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL15598359 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21325433 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL23244 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL23663918 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21013017 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21699244 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL20576343 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL14369486 | 0.97 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080213246-A1 | Supplements For Pain Management | RELEANA, LLC | 2008-09-04 | — | — | US | claimed |
| US-20080175899-A1 | FORMULATION FOR PROMOTING SINUS HEALTH IN NASAL CAVITIES | NATIONAL BANK OF CANADA (CA) | 2008-07-24 | — | — | US | claimed |
| EP-0971743-B1 | STABILIZED MEDICAMENTS CONTAINING CYSTEINYL DERIVATIVES | STANISLAUS FRITZ (DE) | 2006-07-12 | — | — | EP | claimed |
| US-20240108727-A1 | EUTECTIC MATRIX FOR NUTRACEUTICAL COMPOSITIONS | INOVOBIOLOGIC, INC. (CA) | 2024-04-04 | — | — | US | disclosed |
| US-11890269-B2 | Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances | RESEARCH CANCER INSTITUTE OF AMERICA (US) | 2024-02-06 | — | — | US | disclosed |
| CN-117223773-A | Low-flavonol glycoside black tea and preparation method thereof | 浙江大学 | 2023-12-15 | — | — | CN | disclosed |
| US-20230355726-A1 | FIBRINOLYTIC ENZYME COMPOSITION FOR FIBROSIS TREATMENT | ADVANCED ENZYME TECHNOLOGIES LTD. (IN) | 2023-11-09 | — | — | US | disclosed |
| WO-2023212607-A1 | INFLUX VITAMINS AND DRINKS, WITH ZINC IONOPHORIC INFLUX | BLACK STEPHEN (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023212609-A1 | INFLUX VITAMINS AND DRINKS, WITH ZINC IONOPHORIC INFLUX | BLACK STEPHEN (US) | 2023-11-02 | — | — | WO | disclosed |
| US-20230009337-A1 | Liberty Vitamins and Drinks | BLACK STEPHEN PAUL (US) | 2023-01-12 | — | — | US | disclosed |
| EP-4106725-A1 | WATER-SOLUBLE SOLID DISPERSION OF QUERCETIN, FORMS THEREOF, A METHOD OF OBTAINING THEREOF, USE OF ALKALINE AGENT, AND A KIT | "Scientific Industrial Centre "Borshchahivskiy Chemical Pharmaceutical Plant" Public Joint-Stock Company (UA) | 2022-12-28 | — | — | EP | disclosed |
| EP-1034270-A1 | COMPOSITIONS AND METHODS OF USE OF HET | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2000-09-13 | — | — | EP | disclosed |
| WO-1999059578-A1 | TRITERPENE COMPOSITIONS AND METHODS FOR USE THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 1999-11-25 | — | — | WO | disclosed |
| US-5976568-A | TOTAL MODULAR SYSTEM OF MULTIVITAMIN AND MINERAL SUPPLEMENTATION COMPOSED OF 7 DISTINCT MODULES FOR IMPROVING PUBLIC HEALTH BY INSURING ADEQUATE INTAKE OF MICRONUTRIENTS NEEDED FOR DISEASE PREVENTION AND PROTECTION AGAINST | Medical Doctors' Research Institute, Inc. (US) | 1999-11-02 | — | — | US | disclosed |
| WO-1999028466-A9 | COMPOSITIONS AND METHODS OF USE OF HET | UNIV TEXAS (US) | 1999-09-10 | — | — | WO | disclosed |
| US-5948443-A | PREVENTION, THERAPY CARDIOVASCULAR DISORDERS | MEDICAL DOCTOR'S RESEARCH INSTITUTE, INC. (US) | 1999-09-07 | — | — | US | disclosed |
| CN-1226586-A | Treated red pigment from radish and extraction thereof | RUIBAO NATURAL PIGMENTS CO LTD (CN) | 1999-08-25 | — | — | CN | disclosed |
| WO-1999028466-A1 | COMPOSITIONS AND METHODS OF USE OF HET | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-06-10 | — | — | WO | disclosed |
| EP-0412211-A1 | Cancer therapy system | THERAPEUTICAL SYSTEMS CORPORATION (US) | 1991-02-13 | — | — | EP | disclosed |
| US-4935450-A | Cancer therapy system for effecting oncolysis of malignant neoplasms | THERAPEUTICAL SYSTEMS CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108727-A1 | EUTECTIC MATRIX FOR NUTRACEUTICAL COMPOSITIONS | BHMT2, SELENOI, PRMT6 | KDM4E 293/4885XDH 1015/4885MAOA 4065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.